Vitrolife AB logo

VITR - Vitrolife AB News Story

SEK244.8 2.6  1.1%

Last Trade - 8:06am

Sector
Healthcare
Size
Mid Cap
Market Cap £2.32bn
Enterprise Value £2.26bn
Revenue £117.4m
Position in Universe 183rd / 1787

BRIEF-Vitrolife Q2 EBITDA Down At SEK 40 Million

Mon 13th July, 2020 7:03am
July 13 (Reuters) - Vitrolife AB  VITR.ST :
    * INTERIM REPORT JANUARY - JUNE 2020: EXTENSIVE IMPACT OF
COVID-19
    * Q2 SALES SEK 209 MILLION VERSUS SEK 381 MILLION YEAR AGO
    * SALES WERE NEGATIVELY IMPACTED BY A DECREASE IN DEMAND DUE
TO
COVID-19
    * DEMAND WAS SIGNIFICANTLY HIGHER AT END OF QUARTER COMPARED
TO
BEGINNING OF QUARTER.
    * Q2 EBITDA SEK 40 MILLION VERSUS SEK 146 MILLION YEAR AGO
    * Q2 NET INCOME SEK 12 MILLION VERSUS SEK 95 MILLION YEAR
AGO

Source text for Eikon:  ID:nWkrmPgr2 
Further company coverage:  VITR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.